Susan Marie Harte, APN Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 100 E Main St, Tuckerton, NJ 08087 Phone: 609-296-4014 Fax: 609-296-5735 |
News Archive
Premera Blue Cross and Express Scripts today announced an early renewal of the companies' long-standing pharmacy benefit agreement. The partnership, which began in 1999, will now extend through at least 2019.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Research by a group of Montreal scientists calls into question one of the most basic assumptions of human genetics: that when it comes to DNA, every cell in the body is essentially identical to every other cell. Their results appear in the July issue of the journal Human Mutation.
› Verified 8 days ago